Recall: D-0136-2020

Class II - Potentially Harmful

Class IIClassification

2019-10-02Initiated

TerminatedStatus

Pfizer Inc.Firm

Product

10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13

Reason

Lack of Assurance of Sterility: Bag has the potential to leak.

Distribution

Nationwide in the United States and Puerto Rico

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.